Figure 4From: Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reductionEffect of different fibrates on HDL-C level (vs. placebo), HDL-C elevations vs. baseline during a treatment usually were significantly higher [32],[39],[41–45],[48].Back to article page